Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$58.6M |
| 2 |
B
Barrick Mining
B
|
+$42.7M |
| 3 |
Henry Schein
HSIC
|
+$41.4M |
| 4 |
Qualcomm
QCOM
|
+$28.7M |
| 5 |
Republic Services
RSG
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMR
KINDER MORGAN MANAGEMENT LLC
KMR
|
+$64.4M |
| 2 |
General Dynamics
GD
|
+$35.5M |
| 3 |
THI
TIM HORTONS INC COM, CANADA
THI
|
+$31.8M |
| 4 |
Apple
AAPL
|
+$30.2M |
| 5 |
Johnson & Johnson
JNJ
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.42% |
| 2 | Technology | 13.9% |
| 3 | Industrials | 10.95% |
| 4 | Consumer Staples | 10.07% |
| 5 | Energy | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1676
DELISTED
Endologix Inc
ELGX
| $1.09M | ﹤0.01% |
7,130
+290
| +4% | +$36.2K |
|
1677
Innospec
IOSP
$2.31B
| $1.09M | ﹤0.01% |
25,500
+600
| +2% | +$24.6K |
|
|
HZNP
1678
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.09M | ﹤0.01% |
84,500
+26,200
| +45% | +$328K |
|
|
TTPH
1679
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $1.09M | ﹤0.01% |
+1,370
| New | +$738K |
|
1680
Emergent Biosolutions
EBS
$228M
| $1.09M | ﹤0.01% |
39,900
+1,000
| +3% | +$23.8K |
|
|
ALOG
1681
DELISTED
Analogic Corp
ALOG
| $1.08M | ﹤0.01% |
12,800
| – | – |
|
|
CLDT
1682
Chatham Lodging
CLDT
$580M
| $1.08M | ﹤0.01% |
37,300
+5,200
| +16% | +$137K |
|
1683
Sabre
SABR
$803M
| $1.08M | ﹤0.01% |
+53,300
| New | +$965K |
|
|
PEGI
1684
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.08M | ﹤0.01% |
43,800
+6,000
| +16% | +$162K |
|
1685
Regis Corp
RGS
$68.3M
| $1.08M | ﹤0.01% |
3,220
| – | – |
|
|
LOCK
1686
DELISTED
LifeLock, Inc.
LOCK
| $1.08M | ﹤0.01% |
58,300
+8,200
| +16% | +$135K |
|
|
CIR
1687
DELISTED
CIRCOR International, Inc
CIR
| $1.07M | ﹤0.01% |
17,800
+300
| +2% | +$19.7K |
|
1688
WesBanco
WSBC
$4.05B
| $1.07M | ﹤0.01% |
30,800
+600
| +2% | +$20K |
|
|
MTGE
1689
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $1.07M | ﹤0.01% |
56,900
+1,200
| +2% | +$23.6K |
|
1690
Amkor Technology
AMKR
$13.5B
| $1.07M | ﹤0.01% |
150,700
+4,000
| +3% | +$27.7K |
|
1691
ESCO Technologies
ESE
$7.65B
| $1.07M | ﹤0.01% |
29,000
| – | – |
|
|
BGG
1692
DELISTED
Briggs & Stratton Corp.
BGG
| $1.07M | ﹤0.01% |
52,400
| – | – |
|
1693
Flotek Industries
FTK
$1.41B
| $1.07M | ﹤0.01% |
9,517
+317
| +3% | +$39.2K |
|
|
TPC
1694
Tutor Perini Cor
TPC
$5.13B
| $1.07M | ﹤0.01% |
44,400
+900
| +2% | +$22.5K |
|
|
QUOT
1695
DELISTED
Quotient Technology Inc
QUOT
| $1.06M | ﹤0.01% |
+60,000
| New | +$893K |
|
|
CSR
1696
Centerspace
CSR
$920M
| $1.06M | ﹤0.01% |
13,020
+830
| +7% | +$67.6K |
|
1697
Sonic Automotive
SAH
$2.55B
| $1.06M | ﹤0.01% |
39,300
| – | – |
|
1698
Rayonier Advanced Materials
RYAM
$590M
| $1.06M | ﹤0.01% |
47,550
+6,700
| +16% | +$177K |
|
|
VOLC
1699
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $1.06M | ﹤0.01% |
59,300
+1,400
| +2% | +$16.8K |
|
|
TBI
1700
Trueblue
TBI
$310M
| $1.06M | ﹤0.01% |
47,600
+1,100
| +2% | +$26.1K |
|
Similar funds
Swiss National Bank's Q4 2014 Portfolio in Review
As of Q4 2014, Swiss National Bank held 2,649 positions worth $26.7B, up 2.3% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Swiss National Bank's Q4 2014 filing shows 120 new, 1,249 increased, 564 reduced and 81 closed positions. Its largest new stake was Stellantis: 7,902,518 shares worth $59.9M. The largest sale was KINDER MORGAN MANAGEMENT LLC, an estimated $64.4M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
- Swiss National Bank's largest Q4 2014 buy was Stellantis: 7,902,518 shares worth $59.9M.
- Swiss National Bank added most to Barrick Mining in Q4 2014, an estimated $42.7M increase.
- Swiss National Bank's biggest Q4 2014 reduction was Apple, cutting an estimated $30.2M.
- Swiss National Bank fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $64.4M.
- Swiss National Bank's ten largest holdings make up 13% of its $26.7B portfolio in Q4 2014.
- Swiss National Bank opened 120 new positions and closed 81 in Q4 2014.
- Swiss National Bank's portfolio value rose 2.3% quarter-over-quarter to $26.7B.
Based on Swiss National Bank's 13F filing for Q4 2014, filed 3 Feb 2015.